Registered entities
Seres Therapeutics, Inc.
Reg. No. 274326290United States
Innovation
21 patent families (10 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 21,855 times.
| Year | Filings |
|---|---|
| 2015 | 6 |
| 2016 | 7 |
| 2017 | 10 |
| 2018 | 6 |
| 2019 | 13 |
| 2020 | 10 |
| 2021 | 13 |
| 2022 | 11 |
| 2023 | 9 |
| 2024 | 12 |
| 2025 | 10 |
| 2026 | 2 |
Social engagement
Social engagement: 25.7K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
10 investors on record; lead investors include Enso Ventures, Alexandria, Flagship Pioneering, Mayo Clinic Business Accelerator.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 50% |
| Private equity | 1 | 10% |
| Other / undisclosed | 4 | 40% |
Recent activity
2 Mar 2026
Leadership hire
Executive Chair and Interim CEO
24 Nov 2025
Event
Piper Sandler Healthcare Conference
30 Oct 2025
Event
Q3 earnings and business updates